MCHP vs STM: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: MCHP is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MCHP and STM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MCHP and STM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Microchip Technology Incorporated is a large US semiconductor company focused on smart, connected, embedded-control solutions. Its core product is microcontrollers (MCUs), the small brains that run cars, appliances, factory equipment, and countless devices, complemented by analog chips, connectivity and wireless products, memory, and FPGAs (programmable logic). It serves a diverse mix of end markets, with heavy exposure to automotive and industrial plus aerospace and defense, data center and computing, communications, and consumer. Because its chips go into so many products, Microchip is a broad proxy for embedded electronics demand rather than a bet on any single application.

Full MCHP guide

STMicroelectronics designs and manufactures a broad range of semiconductors, including analog chips, power and discrete devices (notably silicon carbide, where it holds the largest global share at roughly a third of the market), microcontrollers, MEMS sensors, and RF products. Its customers are concentrated in automotive (electrification, ADAS, body and safety electronics) and industrial (factory automation, power conversion, energy), with a more cyclical consumer and personal-electronics business layered on top. Unlike fabless designers, ST owns its fabs, which makes it capital-intensive and highly sensitive to factory utilization, a dynamic that has weighed heavily on margins during the recent downturn.

Full STM guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• MCHP drivers: Recovery from the inventory correction; Margin restoration and the nine-point plan.
• STM drivers: Silicon carbide and automotive electrification; Cyclical recovery off the trough.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The dominant risk is semiconductor cyclicality: demand in automotive, industrial, and other end markets can soften quickly, and the current recovery could stall or reverse if customers over-ordered again or the economy weakens, hitting revenue and margins hard. For STM, sTM is deeply cyclical and capital-intensive, so weak factory utilization can compress margins sharply, as it did in 2025 when operating margin fell near breakeven.

Pick MCHP if you believe its drivers more; STM if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MCHP and STM guides.

MCHP. These figures are approximate and tied to the asOf date; verify live numbers and the latest filings before acting. Microchip reports on a fiscal year that ends in late March, so its fiscal quarters do not line up with calendar quarters, which can confuse comparisons. For a cyclical chipmaker, earnings multiples are most meaningful in the context of the cycle: a low multiple on recovering earnings can still be reasonable, while a high one near a trough may overstate value.

STM. STM's valuation looks expensive on forward earnings largely because profits are depressed at the bottom of the cycle, not because the business is structurally rich. Revenue troughed near $3.1 billion in Q1 2026 with gross margin around 33.8%, well below the 44 to 46% level management targets in its longer-term model. The multiple therefore embeds an expectation that margins and earnings recover meaningfully over the next couple of years.

Headline figures (approximate, Jul 2026): MCHP shows revenue trend Recovering; several consecutive quarters of sequential growth (fiscal Q4 2026 ~$1.31 billion, up ~35% year over year), profitability Returning after a downturn trough; margins improving as utilization and inventory normalize under the nine-point plan, balance sheet Carries meaningful debt but reducing net debt; operating cash flow now covering debt service and the dividend, dividend Pays a dividend, but it was cut in May 2025 to prioritize debt reduction (recent quarterly payout ~45.5 cents; yield roughly in the low-single-digit percent range); STM shows revenue (ttm) ~$12B, fy2025 revenue ~$11.8B (down ~11%), q1 2026 revenue ~$3.1B (up ~23% YoY), q1 2026 gross margin ~33.8%.

MCHP and STM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MCHP and STM exposure against your real portfolio. It is not an investment adviser.